Medical/Pharmaceuticals Newswire
Major Study of Opiate Use in Children's Hospitals Provides Simple Steps to Alleviate Harm
STANFORD, Calif.-(Business Wire)-October 6, 2008 - Hospitalized kids with painful ailments from broken bones to cancer are often dosed with strong, painkilling drugs known as opiates. The medications block pain, but they can have nasty side effects. Constipation, for instance, is one side effect...
Research and Markets: The Latest Hong Kong Pharmaceuticals and Healthcare Report Q3 2008: Read the Latest Forecasts, Industry Trends & Key Growth Factors
DUBLIN, Ireland-(Business Wire)-October 6, 2008 - Research and Markets . US drugmakers have expressed concerns about the lengthy approval procedures for new pharmaceuticals, which effectively shorten the period of patent protection by 6 months. Moreover, US are worried that the Hong Kong...
Allergan Announces Quarterly Conference Call
IRVINE, Calif.-(Business Wire)-October 3, 2008 - Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jeff Edwards, Executive Vice President, Finance and Business Development, Chief Financial Officer, discuss the Company's third...
Critical Therapeutics, Inc. Announces Effectiveness of Registration Statement for the Proposed Merger with Cornerstone BioPharma Holdings, Inc.
LEXINGTON, Mass.-(Business Wire)-October 3, 2008 - Critical Therapeutics, Inc. (NASDAQ: CRTX) announced today that the Securities and Exchange Commission, or the SEC, has declared effective its Registration Statement on Form S-4 containing the Proxy Statement/Prospectus relating to the previously...
Oscient Pharmaceuticals Receives NASDAQ Notice
WALTHAM, Mass.-(Business Wire)-October 3, 2008 - Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) today received notification from the Listings Qualifications Department of The NASDAQ Stock Market LLC that, as of October 2, 2008, the Company's market value of publicly held shares ("MVPHS") had...
Pfizer Invites Public to View and Listen to Webcast of October 28 Analyst and Investor Meeting at ACR
NEW YORK-(Business Wire)-October 3, 2008 - Pfizer Inc invites investors, media and the general public to view and listen to a webcast of a presentation by Pfizer's pain and inflammation leadership team at an analyst and investor meeting on Tuesday, October 28, 2008 at 6:00 p.m. Pacific Daylight...
Catalyst Health Solutions Named Again to Washington Business Journal's "50 Fastest Growing Companies" List
ROCKVILLE, Md.-(Business Wire)-October 3, 2008 - Catalyst Health Solutions, Inc. (NASDAQ:CHSI) (formerly HealthExtras, Inc.), a leading manager of prescription drug benefits, was named for the second consecutive year by the Washington Business Journal as one of the fastest growing companies in the...
Iran's Drug Expenditure to Grow by an Average Of 14.8% Year-On-Year to Reach IRR34, 494bn (US$3.52bn) By the End Of 2012
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets Other Healthcare Data Forecasts Table: Other Health Indicators Key Risks To Our Forecast Scenario Competitive Landscape Company Profiles Multinationals Novartis Merck & Co Pfizer GlaxoSmithKline Sanofi-Aventis Indigenous...
York Pharma Plc Announces The Acquisition Of Leading Dermatological & Wound Care Brands
HITCHEN, England-(Business Wire)-October 3, 2008 - York Pharma Plc (AIM: YRK) announces the acquisition of the worldwide commercial rights to two leading skin care and wound healing products. At the same time the company has raised $51.2 million to finance the product acquisition and support...
Amgen Appoints Francois de Carbonnel to the Company's Board of Directors
THOUSAND OAKS, Calif.-(Business Wire)-October 3, 2008 - Amgen (NASDAQ:AMGN) announced today that its Board of Directors has appointed Francois de Carbonnel to the Company's Board. Mr. de Carbonnel, 61, is a consultant and corporate financial advisor. He is also chairman of the board of Thomson...
Omnicare to Release Third-Quarter Earnings and Hold Conference Call on Thursday, October 30, 2008
COVINGTON, Ky.-(Business Wire)-October 3, 2008 - Omnicare, Inc. (NYSE:OCR - News) will release its financial results for the third quarter ended September 30, 2008, on Thursday, October 30, 2008, before the opening of trading on the New York Stock Exchange. Omnicare will hold its quarterly...
Bangladesh Pharmaceutical Market Had a Valuation of US$700mn in 2007 and That a Compound Annual Growth Rate (CAGR) Of 18.79% through To 2012 Can Be Expected
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets Other Healthcare Data Forecasts Table: Other Healthcare Data And Forecasts Key Risks To BMI's Forecasts Competitive Landscape Company Profiles Eskayef Bangladesh Square Pharmaceuticals Renata Beximco Pharmaceuticals BMI...
Canon U.S.A. Showcases the CR-1 Non-Mydriatic Digital Retinal Camera at Vision Expo West
LAS VEGAS-(Business Wire)-October 3, 2008 - At Vision Expo West, Canon U.S.A., Inc., a leader in digital imaging solutions, will showcase its CR-1 Non-Mydriatic Digital Retinal Camera and its complete line of total digital imaging and workflow management solutions for eyecare professionals, in booth...
Microfluidics Nanotechnology Expert to Speak at National Nano Engineering Conference in Boston November 12-13
NEWTON, Mass.-(Business Wire)-October 3, 2008 - Microfluidics, a division of Microfluidics International Corporation (OTCBB: MFLU), has announced that the company's CTO and nationally renowned nanotechnology applications expert, Thomai (Mimi) Panagiotou, Ph.D, will be presenting a talk at the 2008...
A Pink Hummer, Pink Carpet and 12 Women on a Mission
WILLIAMSBURG, Va.-(Business Wire)-October 3, 2008 - They'll be arriving in a hot pink Hummer, strolling out onto a hot pink carpet and escorted by a colorful Good Health Fairy - all to kick-off the 2nd annual Pink Carpet Event premiering the "2009 A Calendar to Live By." Produced by a group of young...
PharMerica to Present at JMP Securities Third Annual Healthcare Focus Conference
LOUISVILLE, Ky.-(Business Wire)-October 3, 2008 - PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy and hospital pharmacy management services, today announced that Michael J. Culotta, Executive Vice President and Chief Financial Officer, will make a presentation...
Ferro Announces Agreement to Sell Fine Chemical Business
CLEVELAND-(Business Wire)-October 3, 2008 - Ferro Corporation (NYSE: FOE) announced today that it has signed an asset purchase agreement with Novolyte Technologies LP, an affiliate of Arsenal Capital Management LP, to sell its Fine Chemicals business for $66 million in cash. "This sale is consistent...
CVS Caremark Cites Numerous Inaccuracies in Antitrust Memo Submitted to Longs Board
WOONSOCKET, R.I.-(Business Wire)-October 3, 2008 - CVS Caremark Corporation (NYSE:CVS) today took strong exception with a memorandum recently submitted to the Board of Directors of Longs Drug Stores Corporation (NYSE:LDG) by a law firm retained by CtW Investment Group, as follows: We are aware...
The EuroBiO 2008 "Call For Change Report"
PARIS-(Business Wire)-October 3, 2008 - EuroBiO 2008, (www.eurobio2008.com), THE Life Sciences Event of the EU Presidency awarded prestigious EU Presidency Label, will take place at the Palais des Congres conference centre in Paris from Tuesday, October 7th to Thursday, October 9th inclusive. During...
Examine the Chinese Pharmaceuticals and Healthcare Industry with this Comprehensive Report, Q3 2008
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets Other Healthcare Data Forecasts Key Risks To BMI's Forecast Scenario Competitive Landscape Top Ten Chinese Pharmaceutical Companies In 2007 Top Ten Chinese Retail Pharmacy Chains In 2007 Company Profiles Leading Multinational...
Examine Thailand's Pharmaceuticals and Healthcare Industry with this Comprehensive Report Q3 2008
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets Export/Import Forecasts Other Healthcare Data Forecasts Key Risks To BMI's Forecast Scenario Competitive Landscape Company Profiles Leading Multinational Manufacturers BMI Forecast Modelling How We Generate Our Pharmaceutical...
Examine Zimbabwe's Pharmaceuticals and Healthcare Industry with this Comprehensive Report, Q3 2008
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets to an unnamed foreign investor. CAPS Holdings is continuing its investment in capital projects. However, the loss of its Indian backer is likely to make it challenging to obtain hard currency to fund such activities. Key...
Delivering Therapeutic Proteins - An Analysis of the Special Formulations and Delivery Strategies Required for Complex Therapeutic Substances
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets has announced the addition of the "Delivering Therapeutic Proteins - Drugs, Devices and Delivering Strategies" report to their offering. While the ability of recombinant protein drugs to treat previously refractory conditions...
New Publication Shows Cleviprex(TM) Provides More Precise Blood Pressure Control in Cardiac Surgery Patients
PARSIPPANY, N.J.-(Business Wire)-October 3, 2008 - The Medicines Company (NASDAQ: MDCO) today announced that ECLIPSE, the largest safety program to date comparing intravenous antihypertensive therapies, has been published in the October issue of Anesthesia and Analgesia. Results show Cleviprex(TM...
Wall Street Journal Selects PhyloChip Developed on the Affymetrix Platform as a Top Technology Innovation
SANTA CLARA, Calif.-(Business Wire)-October 3, 2008 - Affymetrix Inc. (Nasdaq:AFFX) announced today that the PhyloChip, a custom Affymetrix microarray developed by Lawrence Berkeley National Laboratory, won the bronze prize in the 2008 Wall Street Journal Technology Innovation Awards. The...
Examine the Japanese Pharmaceuticals and Healthcare Industry with This Comprehensive Report, Q3 2008
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets - AstraZeneca - Takeda - Astellas - Eisai - Daiichi-Sankyo - Sawai Pharmaceutical For more information visit http://www.researchandmarkets.com/research/6d2dfc/japan_pharmaceutic
Independent Forecasts and Competitive Intelligence on United Arab Emirates' Pharmaceuticals and Healthcare Industry for Q3 08
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets -NeoPharma For more information visit http://www.researchandmarkets.com/research/15d57b/united_arab_emirat
Who's Developing What in Global Biopharmaceuticals? Read This Assessment of 50 Leading Companies and Discover the Latest Research and Performance
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets has announced the addition of the "Who's Developing What in Global Biopharmaceuticals?" report to their offering. A critical assessment of 50 leading companies, their research, products, partners and performance. The...
New Drug Delivery for Self-Administration Report now Available
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets has announced the addition of the "Drug Delivery for Self-Administration Report - Technologies, Combination" report to their offering. As the trend toward drug combination products for prescription drugs grows, a number of...
Microneedles in Medicine Report - Technology, Markets and Prospects
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets has announced the addition of the "Microneedles in Medicine - Technology, Markets and Prospects" report to their offering. Advances in the processing of materials on a micro-scale have led to the development and introduction of...
Examine Current and Possible Opportunities within the Transdermal Skin Patches Markets
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets has announced the addition of the "Transdermal Skin Patches - Markets and Opportunities" report to their offering. Advances in synthetic materials and skin patch designs have led to transdermal drug delivery products that are...
An Essential Report on Diagnostic Imaging Agents - Discover the Next Generation of New Contrast Agents to Detect Metabolic Changes at the Molecular Level
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets and commercial research programs. The potential for the next generation of diagnostic imaging agents is significant. SPECT and PET tracers have been developed to measure oxidative metabolism, fatty acid and amino acid...
Genentech, GlycArt and Roche Enter into Collaboration Agreement for Potential Cancer Therapy
SCHLIEREN/BASEL, Switzerland & SOUTH SAN FRANCISCO, Calif.-(Business Wire)-October 3, 2008 - Genentech, Inc. (NYSE:DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX:ROG) have entered into a collaboration agreement, including a license from GlycArt to Genentech, for the joint...
Detailed Information Resource for OTC Healthcare in Asia-Pacific with Forecasts to 2011
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets has announced the addition of the "OTC Healthcare in Asia-pacific to 2011" report to their offering. This databook is a detailed information resource covering all the key data points on OTC Healthcare in Asia Pacific. It includes...
Invitrogen Sets Third Quarter Earnings Release Date for Tuesday, October 21, 2008
CARLSBAD, Calif.-(Business Wire)-October 2, 2008 - Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, will announce its third quarter 2008 earnings on Tuesday, October 21, 2008, after Market close. Following the...
Repros Therapeutics Inc. Announces Closing of Previously Announced Direct Registered Offering
THE WOODLANDS, Texas-(Business Wire)-October 2, 2008 - Repros Therapeutics Inc. (NasdaqGM:RPRX) today announces that it has consummated its previously announced sale of an aggregate of 2.4 million shares of its common stock resulting in net proceeds to the Company of approximately $15.5 million...
Phase Forward Founder Steps Down from Day-to-Day Responsibilities
WALTHAM, Mass.-(Business Wire)-October 2, 2008 - Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Paul Bleicher, M.D., Ph.D. will step down from his day-to-day operational responsibilities at the end of this...
District Court Affirms Patent Infringement Rulings and Finds That Amgen is Entitled to a Permanent Injunction against Roche
THOUSAND OAKS, Calif.-(Business Wire)-October 2, 2008 - Amgen (NASDAQ:AMGN) announced today that the United States (U.S.) District Court in Boston issued its written decision upholding the prior jury verdict and court rulings regarding the infringement, validity and enforceability of 10 claims of...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-October 2, 2008 - Genentech, Inc. (NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...
Final Call to Register for BioPartnering Europe (BPE)
LONDON-(Business Wire)-October 2, 2008 - There are now just ten days to go until this year's BioPartnering Europe which will be held on 12th-14th October, 2008 at the Queen Elizabeth Conference Centre in London, UK. With nearly 1200 delegates from Europe, the US and Asia now registered to attend...
Exelixis Files IND Application for XL888
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-October 2, 2008 - Exelixis, Inc. (Nasdaq:EXEL) announced today that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for XL888, a novel anticancer compound. XL888 is an orally available small...
Response Genetics, Inc. to Present at the Maxim Group Growth Conference
LOS ANGELES-(Business Wire)-October 2, 2008 - Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sales of molecular diagnostic tests for cancer, today announced that its management will present at the Maxim Group Growth Conference in New York on Oct. 7. The conference...
PPD Announces Third Quarter 2008 Earnings Release, Webcast and Conference Call
WILMINGTON, N.C.-(Business Wire)-October 2, 2008 - PPD, Inc. (NASDAQ:PPDI) will release its third quarter 2008 financial results on Tuesday, October 21, 2008, after the market closes. The earnings release will be available on the PPD Web site at http://www.ppdi.com, FirstCall and Business Wire. On...
CSHP Selects Jay Rho as 2008 Pharmacist of the Year and Mirta Millares for Distinguished Service
SACRAMENTO, Calif.-(Business Wire)-October 2, 2008 - At a time when an increasing number of Californians are managing their health with daily medications and pharmacists are playing a growing leadership role in patient care, the California Society of Health-System Pharmacists (CSHP) has recognized...
State of Ohio Renews Behavioral Health Contract with OptumHealth
GOLDEN VALLEY, Minn.-(Business Wire)-October 2, 2008 - OptumHealth Inc. today announced it has been awarded a three-year renewal of its behavioral health contract serving 54,000 State of Ohio employees and their families. OptumHealth will provide comprehensive mental health and substance abuse...
New PCMA Research: State Legislative Proposals Restricting Access to Generic Medicines Would Increase Costs $29 Billion Over 10 Years
WASHINGTON-(Business Wire)-October 2, 2008 - Legislative proposals to exempt certain classes of drugs from generic substitution laws would increase costs by more than $29 billion over ten years if enacted nationally and provide no safety or clinical benefit for patients, according to a study...
OPKO Acquires Worldwide Ophthalmic Rights to Teva's Budesonide for Inflammatory and Allergic Ocular Conditions
MIAMI-(Business Wire)-October 2, 2008 - OPKO Health, Inc. (AMEX:OPK) today announced that it has acquired exclusive worldwide rights from Teva Pharmaceuticals Industries Ltd. (TEVA) to Teva's proprietary formulation of budesonide for the treatment of various inflammatory and allergic conditions of...
Aeolus Pharmaceuticals Completes Third Closing of Senior Convertible Debt Financing
LAGUNA NIGUEL, Calif.-(Business Wire)-October 2, 2008 - Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS), today announced that it has raised an additional $125,000 through the sale of $125,000 in aggregate principal amount of its newly issued Senior Convertible Notes and warrants to selected...
PanGenex (PGXC) Provides Product Update on LIPIDEME(TM)
TAMPA, Fla.-(Business Wire)-October 2, 2008 - In June, 2008, PanGenex Corporation (Pink Sheets:PGXC) formally introduced LIPIDEME(TM), the all-natural product formulated to address cardiovascular health by having a positive impact on blood lipids. LIPIDEME, made from scientifically proven...
Cubist Pharmaceuticals to Announce Third Quarter 2008 Financial Results on Thursday, October 16, 2008
LEXINGTON, Mass.-(Business Wire)-October 2, 2008 - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its third quarter 2008 financial results at 4:00 p.m. EDT on Thursday, October 16th, 2008. In connection with this announcement, Cubist will host a conference call and live audio webcast (with...
Standard & Poor's Initiates Factual Stock Report Coverage on Mymetics Corporation
NEW YORK-(Business Wire)-October 2, 2008 - Standard & Poor's announced today that it has commenced Factual Stock Report coverage on Mymetics Corporation. Mymetics Corporation (OTCBB:MYMX), is a biotechnology company focused on developing prophylactic vaccines, presently focusing on vaccines...
CLC bio Partners with Illumina to Provide Next Generation Sequencing Analysis Technology
AARHUS, Denmark-(Business Wire)-October 2, 2008 - Following an overwhelming reception of CLC Genomics Workbench 1.0, CLC bio is happy to announce the release of its next major version of their flagship product: CLC Genomics Workbench 2.0. Additionally, CLC bio has taken another important step in...
Provectus Lead Investigator Professor John F. Thompson Presents at "Perspectives in Melanoma XII" Conference
KNOXVILLE, Tenn.-(Business Wire)-October 2, 2008 - Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that the lead investigator for its Phase 2 melanoma study, Professor John F Thompson, MD, today presented clinical data...
PharMerica Corporation to Broadcast Third Quarter Results Conference Call Live on the Internet
LOUISVILLE, Ky.-(Business Wire)-October 2, 2008 - PharMerica Corporation (NYSE: PMC) announced today that it will provide an online simulcast of its third quarter earnings conference call on Friday, October 31, 2008. The Company's results for the third quarter ended September 30, 2008, will be...
CLSI Publishes Guideline for Characterization and Qualification of Commutable Reference Materials for Laboratory Medicine
WAYNE, Pa.-(Business Wire)-October 2, 2008 - Reference materials are an important requisite for assuring reliable laboratory measurements and appropriate patient care. To ensure that a reference material is suitable for its intended purpose, its commutability characteristics need to be assessed in a...
Research and Markets: A Detailed Report on the OTC Healthcare Industry in Ireland to 2011, Providing a Category Analysis & Leading Company Profiles
DUBLIN, Ireland-(Business Wire)-October 2, 2008 - Research and Markets has announced the addition of the "OTC Healthcare in Ireland to 2011" report to their offering. This databook is a detailed information resource covering all the key data points on OTC Healthcare in Ireland. It includes...
Mannatech to Participate in Annual Albuquerque Balloon Fiesta
COPPELL, Texas-(Business Wire)-October 2, 2008 - Mannatech, Incorporated (NASDAQ:MTEX), a leading developer and provider of dietary supplements and skin care solutions, announced today it has partnered with independent sales Associates from across the nation to participate in the 37th Annual...
Anika Therapeutics Announces Exclusive Canadian Distribution Agreement for ELEVESS(R) with Canderm Pharma Inc.
BEDFORD, Mass.-(Business Wire)-October 2, 2008 - Anika Therapeutics, Inc. (NASDAQ:ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, announced today that it has signed an exclusive agreement with Canderm Pharma, Inc., Canada's leading...
NeuroMetrix Receives FDA 510(k) Clearance for UNIVERSAL(TM) Electrodes used in the Performance of Nerve Conduction Studies
WALTHAM, Mass.-(Business Wire)-October 2, 2008 - NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has received 510(k) clearance for its UNIVERSAL Electrodes from the U.S. Food and Drug Administration (FDA). This regulatory determination by the FDA gives NeuroMetrix clearance to market the...
Q Pharma, Inc. Launches iValidate 2.0
MORRISTOWN, N.J.-(Business Wire)-October 2, 2008 - Q Pharma, Inc., the industry leader in FDA Regulatory and Compliance Solutions, announced today the official release of their online practitioner validation application, iValidate(TM) 2.0. This tool assists Pharmaceutical and Biotechnology companies...
Genta Announces Webcast of 2008 Annual Shareholders Meeting
BERKELEY HEIGHTS, N.J.-(Business Wire)-October 2, 2008 - Genta Incorporated (OTCBB: GNTA) announced that the Company will host a conference call and live audio webcast of its 2008 Annual Meeting of Shareholders. The meeting will be held on Monday, October 6, 2008 at 11:00 a.m., EDT at the...
ArQule Achieves Clinical Milestone in MiT Trial with ARQ 197
WOBURN, Mass.-(Business Wire)-October 2, 2008 - ArQule, Inc. (NASDAQ: ARQL) today announced the expansion of its Phase 2 trial with ARQ 197, a proprietary, orally administered small molecule inhibitor of the c-Met receptor tyrosine kinase, in MiT (Microphthalmia Transcription Factor)-associated...
Nextrials Positions Strategic Sales Force Across the U.S. for Improved Customer Access and Service
SAN RAMON, Calif.-(Business Wire)-October 2, 2008 - Nextrials, Inc., (www.nextrials.com) a leader in clinical research software and services, today announced the addition of regional directors of business development to its sales force. Scott Steward, based in Texas, and Virginia (Giga) Smith, based...
VWR International, LLC Acquires OMNILAB AG, Switzerland
WEST CHESTER, Pa.-(Business Wire)-October 2, 2008 - VWR International, LLC, a leading global laboratory supply company, announced today that it has acquired OMNILAB AG, a Swiss scientific laboratory supply distributor headquartered in Mettmenstetten near Zurich. OMNILAB was founded in 1990 and is...
Celldex Receives $10 Million Milestone Payment
NEEDHAM, Mass.-(Business Wire)-October 2, 2008 - Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that it has received a milestone payment of $10,000,000 from an affiliate of Paul Capital Healthcare (PCH). The payment was triggered by the market launch of Rotarix(R) in the United States...
Progenics Announces Progress and Presentations in HIV Therapy Program
TARRYTOWN, N.Y.-(Business Wire)-October 2, 2008 - Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the completion of enrollment in two, phase 2 clinical studies of PRO 140, an investigational drug that is being developed for treatment of human immunodeficiency virus (HIV) infection...
Bristol-Myers Squibb Appoints Christopher Perley as Devens General Manager
DEVENS, Mass.-(Business Wire)-October 2, 2008 - Bristol-Myers Squibb Company (NYSE:BMY) today announced that Christopher Perley has been named vice president and general manager of its Devens biologics manufacturing facility. In this role, Perley will be responsible for continuing the supervision of...
Osiris Therapeutics to Present at the JMP Securities Healthcare Focus Conference
COLUMBIA, Md.-(Business Wire)-October 2, 2008 - Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, announced today that C. Randal Mills...
Walgreens September Sales Increase 10.0 Percent
DEERFIELD, Ill.-(Business Wire)-October 2, 2008 - Walgreens (NYSE: WAG)(NASDAQ: WAG) had September sales of $4,854,000,000, an increase of 10.0 percent from $4,410,987,000 for the same month in 2007. Sales in comparable stores (those open at least a year) rose 4.7 percent, while comparable store...
Merck Discontinues Development of Investigational Medicine Taranabant for Obesity
WHITEHOUSE STATION, N.J.-(Business Wire)-October 2, 2008 - Merck & Co., Inc. will not seek regulatory approval for taranabant, an investigational medicine, to treat obesity and is discontinuing its Phase III clinical development program for taranabant for obesity. "Available Phase III data...
Physicians Interactive Acquired by Private Investment Firm Perseus L.L.C.
CHICAGO & WASHINGTON-(Business Wire)-October 2, 2008 - Physicians Interactive, the leading provider of emarketing solutions for pharmaceutical, biotech and medical device companies, announced it has been acquired by a fund that is managed by Perseus, L.L.C. from Allscripts Healthcare...
Roche Diagnostics Extends License for Universal ProbeLibrary (UPL) Kits from Exiqon A/S
PENZBERG, Germany-(Business Wire)-October 2, 2008 - Roche Diagnostics and Exiqon A/S, Vedbaek, Denmark, a provider of high-value gene expression analysis products, today announced the signing of an amendment to their 2005 license and distribution agreement for the Universal ProbeLibrary (UPL) that...
Gentium Announces that Italian Court Rejects Plaintiffs' Claims and Ends Legal Proceeding
VILLA GUARDIA, Italy-(Business Wire)-October 2, 2008 - Gentium S.p.A. (NASDAQ: GENT) (the "Company") today announced that the Court of Como issued a decision terminating the legal proceeding brought in August against the Company's Board of Directors and Board of Statutory Auditors. The proceeding...
Rite Aid September Same Store Sales Increase 1.7 Percent
CAMP HILL, Pa.-(Business Wire)-October 2, 2008 - Rite Aid Corporation (NYSE:RAD) today announced sales results for September. Monthly Sales For the four weeks ended September 27, 2008, same store sales increased 1.7 percent over the prior-year period. Front-end same store sales were up 3.4...
EDS Interviews the CEO and President of PanGenex Corporation (PGXC); Issues Strong Buy Recommendation
TAMPA, Fla.-(Business Wire)-October 2, 2008 - PanGenex Corporation (Pink Sheets: PGXC) announced today that CEO and President, Jeff Roman, is featured in a broad scope text interview by Eric David Finance, Inc. (EDS). EDS, a Plainsboro, NJ-based Financial Marketing Consulting Firm, specializes in...
Examine the Who, What, When, Where of Biotechnology R&D with This Pipeline News Report - Therapeutic Area Edition
DUBLIN, Ireland-(Business Wire)-October 2, 2008 - Research and Markets ; - Technology News; - R&D Collaboration Deals; - R&D Licensing Deals; - Mergers & Acquisitions For more information visit http://www.researchandmarkets.com/research/246b38/rd_pipeline_news
Medivisor Inc.; Reiterated 'Speculative Buy' Rating, Target Price $0.87 by Beacon Equity Research
DALLAS-(Business Wire)-October 2, 2008 - Medivisor Inc. (Pink Sheets: MVSR) has received a reiterated Speculative Buy rating with a price target of $0.87 by Beacon Analyst, Victor Sula, Ph.D. The full report is available at http://beaconequity.com/main/Page-data/Adpages/Medivisor-Inc. Anyone...
Presidio Pharmaceuticals, Inc. to Present at the JMP Securities and BioPartnering Europe Healthcare Conferences
SAN FRANCISCO-(Business Wire)-October 2, 2008 - Presidio Pharmaceuticals, Inc. announced today that Mr. Leo Redmond, Chief Financial Officer at Presidio will be presenting an overview of Presidio and an update to its HCV and HIV programs at the Third Annual JMP Securities Healthcare Focus Conference...
Challenges and Opportunities Facing Needle-Free Injection Technology
DUBLIN, Ireland-(Business Wire)-October 2, 2008 - Research and Markets on improved devices for mass immunization in underdeveloped countries. -0- *T Key Topics Covered: - Executive Summary - Parenteral Delivery Market Overview - Drug Injection Devices - Traditional Needle/Syringes - Safety Syringes...
Meda: Acquisition of Product Portfolio from Roche Completed
STOCKHOLM, Sweden-(Business Wire)-October 2, 2008 - Regulatory News: On 15 August 2008, Meda (STO:MEDAA) announced that it reached agreement regarding acquisition of four well established pharmaceuticals from the Swiss pharma company Roche - pending approval from competition authorities. The...
Report: Health Care Quality Improves but Varies Across Different Regions of the Country
WASHINGTON-(Business Wire)-October 2, 2008 - The quality of health care for millions of Americans improved in 2007 but significant variations in performance continue to leave many people receiving substandard care, according to a report released today by the National Committee for Quality...
ImClone Systems Issues Statement
NEW YORK-(Business Wire)-October 2, 2008 - Carl Icahn, Chairman of the Board of ImClone Systems Incorporated (NASDAQ: IMCL), stated that the large Pharma company has completed due diligence and made a proposal not subject to financing or further due diligence. Negotiations between the parties are...
Alcon Announces Third Quarter 2008 Financial Release and Conference Call Dates
HUNENBERG, Switzerland-(Business Wire)-October 1, 2008 - Alcon, Inc. (NYSE: ACL) will report on its third quarter financial results for the period ended September 30, 2008 after the market close on Wednesday, October 22, 2008. Management of the company will host a conference call to discuss these...
Luminex Corporation Hosts Sixth Annual Planet xMap Europe 2008 Symposium
OOSTERHOUT, The Netherlands-(Business Wire)-October 1, 2008 - Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced the agenda for Planet xMAP Europe 2008, the company's annual European multiplexing technology symposium, which will be held 8-9 October, at...
U.S. Food & Drug Administration Approved the use of REYATAZ(R) (atazanavir sulfate) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients
PRINCETON, N.J.-(Business Wire)-October 1, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food & Drug Administration (FDA) approved the use of REYATAZ(R) (atazanavir sulfate) 300 mg once-daily boosted with ritonavir 100 mg as part of combination therapy in...
JMP Securities Healthcare Conference to Be Held in New York
SAN FRANCISCO-(Business Wire)-October 1, 2008 - JMP Group Inc. (NYSE:JMP), an investment banking and alternative asset management firm, announced today that its broker-dealer subsidiary, JMP Securities, will host the third annual JMP Securities Healthcare Focus Conference at Le Parker Meridien in...
PPD Completes Acquisition of InnoPharm
WILMINGTON, N.C.-(Business Wire)-October 1, 2008 - PPD, Inc. (Nasdaq: PPDI) today announced it has completed the acquisition of InnoPharm, an independent contract research organization based in Smolensk, Russia, strengthening its ability to offer Phase II-IV clinical trials support, data...
ETLT Management Announcement
HOUSTON-(Business Wire)-October 1, 2008 - Eternal Technologies Group, Inc. (OTCBB:ETLT) today announced that the reason of the Company's symbol with Q is caused by the lawsuit with WESTERN SECURITIES. But it doesn't impact the company's financial and operation situation. Company is still under the...
HealthPartners Medicare Premiums Increase Three Percent
BLOOMINGTON, Minn.-(Business Wire)-October 1, 2008 - HealthPartners announced today that premiums will increase three percent for HealthPartners Freedom plans which are the most popular. "We are pleased to be able to keep cost increases to a minimum without any cuts in benefits," said Donna...
Vertex Pharmaceuticals Announces Webcast of its Presentation at the JMP Securities Healthcare Focus Conference
CAMBRIDGE, Mass.-(Business Wire)-October 1, 2008 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the JMP Securities Healthcare Focus Conference on Monday, October 6, 2008 at 9:30 a.m. EDT. The presentation will be webcast live...
Exelixis Announces October 6 Webcast of Presentation at the JMP Securities 3rd Annual Healthcare Focus Conference
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-October 1, 2008 - Exelixis, Inc. (Nasdaq:EXEL) announced today that George A. Scangos, PhD, President and Chief Executive Officer of Exelixis, will present at the JMP Securities 3rd Annual Healthcare Focus Conference at 11:30 a.m. ET/8:30 a.m. PT on...
Corning and DSM Announce Successful Pilot Operation of Industrial-Scale Microreactor for cGMP Pharmaceutical Production
CORNING, N.Y.-(Business Wire)-October 1, 2008 - Corning Incorporated (NYSE:GLW) and DSM Pharma Chemicals announced publication of a joint paper at CPhI Worldwide 2008 in Frankfurt, Germany this week, describing a successful, commercially viable demonstration of Corning's microreactor technology...
Alnylam to Webcast Presentation at The Third Annual JMP Securities Healthcare Focus Conference
CAMBRIDGE, Mass.-(Business Wire)-October 1, 2008 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at The Third Annual JMP Securities Healthcare Focus Conference on Tuesday, October 7, 2008, at 1:30...
7th Annual Charlotte Biotechnology Conference to feature Dr. Roger Newton, co-discoverer of Lipitor(R) and founder of Esperion Therapeutics, Inc.
CHARLOTTE, N.C.-(Business Wire)-October 1, 2008 - The University of North Carolina at Charlotte and the Charlotte Research Institute will present the 7th Annual Charlotte Biotechnology Conference (www.CharlotteBiotechnology.com) taking place at the Barnhardt Student Activities Center on October...
NASDAQ Corrects Glitch to Stock Price of Catalyst Health Solutions, Inc.
ROCKVILLE, Md.-(Business Wire)-October 1, 2008 - NASDAQ corrected a technical error that temporarily caused the stock of Catalyst Health Solutions, Inc. (NASDAQ:CHSI) to drop erroneously. The Company's stock is now trading back at market value. About Catalyst Health Solutions, Inc. Catalyst Health...
Mack-Cali Announces Lease Expansion with Pharmaceutical Firm
EDISON, N.J.-(Business Wire)-October 1, 2008 - Mack-Cali Realty Corporation (NYSE: CLI) today announced that Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc., has signed a new nine-year, 35,587 square-foot lease at Harborside Financial Center Plaza 5 in Jersey City, New...
DrFirst Releases Enhancement to Rcopia E-Prescribing to Allow Secure Printing of Prescriptions
ROCKVILLE, Md.-(Business Wire)-October 1, 2008 - Beginning today, hundreds of thousands of physicians across the US will be required to comply with the Medicaid Tamper Resistant Prescription Law of 2007 which is intended to reduce fraud and abuse in the Medicaid program. In a move to bring its...
SAFE-BioPharma Announces Fast, Innovative Identity Proofing Procedure
FT. LEE, N.J.-(Business Wire)-October 1, 2008 - SAFE-BioPharma Association today announced the launch of an innovative, simple, and exceptionally fast procedure for identity proofing and authenticating individuals being equipped with medium assurance digital certificates. The procedure, which...
Patient Safety and Incentives for Continued Innovation Must be Provided in Any Pathway for the Approval of Follow-On Biologics, BIO Tells FTC
WASHINGTON-(Business Wire)-October 1, 2008 - Patient safety and data exclusivity to preserve biomedical innovation should stand at the center of a regulatory approval pathway for follow-on biologics, wrote the Biotechnology Industry Organization (BIO) in comments provided yesterday to the Federal...
OSI Pharmaceuticals Announces Conversion Period for Convertible Notes
MELVILLE, N.Y.-(Business Wire)-October 1, 2008 - OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that its 2% Convertible Senior Notes due 2025 (the "notes") are now convertible at the option of the holders and will remain convertible through December 31, 2008, the last trading day of the...
2008 Mid-Atlantic Bio to be Held October 22-24, 2008
CHANTILLY, Va.-(Business Wire)-October 1, 2008 - Mid-Atlantic Bio: -0- *T WHO...
VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation
BLUE BELL, Pa.-(Business Wire)-October 1, 2008 - VGX Pharmaceuticals (VGX), a developer of DNA vaccines against cancer and infectious diseases that has entered into a definitive merger agreement with Inovio Biomedical (AMEX:INO), announced today that the National Institute of Allergy and...
BIOTECHNICA 2008 to Feature Cornucopia of Cutting-Edge Topics
HANNOVER, Germany-(Business Wire)-October 1, 2008 - Whether it involves new medicines for cancer, innovative vaccines, new plant varieties, energy-saving detergents or genetic fingerprints, biotechnology has become en established fixture in our lives. Running from 7 to 9 October, Europe's biggest...
BIOTECHNICA Promotes Dialogue on European Biotech Goals
HANNOVER, Germany-(Business Wire)-October 1, 2008 - Modern biotechnology plays a vital role in many areas of our lives, including healthcare, food production, manufacturing industry and environmental protection. Yet ethical issues such as the use and control of genetic data continue to generate...
Rite Aid Celebrates Its Pharmacists with 5th Annual Vote for Your Favorite Pharmacist Contest During American Pharmacists Month
CAMP HILL, Pa.-(Business Wire)-October 1, 2008 - To celebrate American Pharmacists Month in October, Rite Aid is asking patients to vote for their Favorite Pharmacist by sharing stories of extraordinary service and telling what makes their pharmacist special. The program, now in its fifth year, is...
The Italian Pharmaceutical Market Experienced Poor Performance in 2007 Read More Inside the Italy Pharmaceuticals And Healthcare Report Q3 2008
DUBLIN, Ireland-(Business Wire)-October 1, 2008 - Research and Markets Medical Devices Table: Italy's Medical Device Market, 2006-2012 (US$bn unless otherwise stated Other Healthcare Data Forecasts Table: Italian Socio-Demographic Indicators Competitive Landscape Company Profiles Leading...
Arriva Pharmaceuticals Granted Protein Production Patent
ALAMEDA, Calif.-(Business Wire)-October 1, 2008 - Arriva Pharmaceuticals, a biopharmaceutical company focused on developing anti-inflammatory therapies, announced today that it had been granted a patent in the U.S. for methods to produce certain proteins in yeast. Among the proteins whose production...
Fitch Affirms Eli Lilly & Co.'s IDR at 'AA'; Outlook Stable
CHICAGO-(Business Wire)-October 1, 2008 - Fitch Ratings has affirmed Eli Lilly and Co.'s (Eli Lilly) ratings as follows: —Issuer Default Rating (IDR) 'AA'; —Bank loan 'AA'; —Senior unsecured debt 'AA'; —Short-term IDR 'F1+'. The Rating Outlook is Stable. The ratings apply...
Pfizer Invites Public to View and Listen to Webcast of October 21 Conference Call with Analysts
NEW YORK-(Business Wire)-October 1, 2008 - Pfizer Inc invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, October 21, 2008. The purpose of the call is to provide an update on Pfizer's results, as...
Inotek Appoints Paul G. Howes as President and CEO
BEVERLY, Mass.-(Business Wire)-October 1, 2008 - Inotek Pharmaceuticals Corporation announced today that it has hired Paul G. Howes as President, CEO and Director. Mr. Howes brings more than twenty years of senior level pharmaceutical experience to Inotek, most recently serving as President of the...
US Centers for Disease Control and Prevention Expands Golden Helix License
BOZEMAN, Mont.-(Business Wire)-October 1, 2008 - Golden Helix, Inc., the global leader in genetic association software, today announced that the US Centers for Disease Control and Prevention (CDC) has expanded its licensing agreement for the Golden Helix SNP and Variation Suite. While the CDC has...
Meridian Bioscience to Present at the William Blair and Company Small-Cap Growth Stock Conference
CINCINNATI-(Business Wire)-October 1, 2008 - Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that the Company has been invited to present at the William Blair and Company Small-Cap Growth Stock Conference on Tuesday, October 7, 2008 at 12:00 p.m. ET at the...
GenomeQuest Announces Integration of GenomeQuest(TM) 5.0 with Invitrogen's Vector NTI Advance(TM) for Genomic Sequence Analysis
WESTBOROUGH, Mass.-(Business Wire)-October 1, 2008 - GenomeQuest and Invitrogen today announced that the GenomeQuest(TM) 5.0 web-based sequence search, analysis and data management platform is now interoperable with Invitrogen's Vector NTI Advance(TM) desktop sequence analysis solution. Ronald...
NovaBay Pharmaceuticals to Present at the Maxim Group Annual Growth Conference
EMERYVILLE, Calif.-(Business Wire)-October 1, 2008 - Dr. Ron Najafi, CEO of NovaBay Pharmaceuticals, Inc. (AMEX: NBY & TSX: NBY, http://www.novabaypharma.com), a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of...
Taconic and Samaritan Pharmaceuticals Announce Availability of New Rat Model to Study Alzheimer's Disease
HUDSON, N.Y.-(Business Wire)-October 1, 2008 - Taconic, one of the largest laboratory rodent providers in the world, together with Samaritan Pharmaceuticals, Inc. (OTC BB:SPHC.OB - News), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, announced the...
An Industry Profile of the Pharmaceuticals Market in Norway - Examine Market Forecasts, Future Trends and the Competitive Environment
DUBLIN, Ireland-(Business Wire)-October 1, 2008 - Research and Markets . Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates. Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy...
Phase Forward to Present at the William Blair Small Cap Growth Stock Conference
WALTHAM, Mass.-(Business Wire)-October 1, 2008 - Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its chief executive officer and president, Bob Weiler, and chief financial officer, Rodger Weismann, will...
RegeneRx to Develop RGN-457 for Cystic Fibrosis
BETHESDA, Md.-(Business Wire)-October 1, 2008 - REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it is seeking a strategic partner to assist in the development of RGN-457 for the treatment of cystic fibrosis (CF). RGN-457 is based on thymosin beta 4 (TB4...
Aeolus Pharmaceuticals Receives $175,000 Milestone Payment From Cardiovascular Company
LAGUNA NIGUEL, Calif.-(Business Wire)-October 1, 2008 - Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today that it has received a milestone payment from ARCA Biopharma, Inc., a privately held cardiovascular-focused company ("ARCA"). In 2003, CPEC, LLC ("CPEC"), a limited liability company...
Thirteen Advocacy Groups Collaborate on New Online Resource Dedicated to Patients with Advanced Breast Cancer
NEW YORK-(Business Wire)-October 1, 2008 - Today, those living with advanced breast cancer now have an online resource available specifically for them. AdvancedBreastCancerCommunity.org is the first comprehensive online resource to serve as a clearinghouse of information for those impacted by...
The New Tripos International Announces Pantheon(TM) a New Open Software Platform for Molecular Modeling and Discovery
ST. LOUIS-(Business Wire)-October 1, 2008 - Tripos International, a leading provider of drug discovery informatics products and services, today announced the development of Pantheon(TM), a new, flexible and powerful software platform created to address the CADD and cheminformatics needs of the...
Mentor Corporation Announces Completion of PurTox(R) 3A Study
SANTA BARBARA, Calif.-(Business Wire)-October 1, 2008 - Mentor Corporation (NYSE:MNT), a leading supplier of medical products for the global aesthetic market, today announced completion of the first of three Phase 3 clinical trials with its purified botulinum Type A neurotoxin (PurTox(R)) for the...
HealthExtras, Inc. Is Now Catalyst Health Solutions, Inc.
ROCKVILLE, Md.-(Business Wire)-October 1, 2008 - Effective immediately, HealthExtras, Inc. has become Catalyst Health Solutions, Inc. and will trade under the NASDAQ ticker symbol "CHSI". "As our largest operating subsidiary, Catalyst Rx has established significant brand recognition among our...
Virostatics' President and CEO, Dr. Franco Lori, to address the 2nd World Conference on Magic Bullets (Ehrlich II) in Nurnberg, Germany
SASSARI, Italy & PRINCETON, N.J.-(Business Wire)-October 1, 2008 - ViroStatics, srl today announced the Company's President and CEO, Dr. Franco Lori, will be speaking at the prestigious 2nd World Conference on Magic Bullets (Ehrlich II) in Nurnberg, Germany on Saturday, October 4th 2008. Dr...
pSivida Release: Results from the Six-Month Interim Readout of the Human PK Iluvien(TM) Study
BOSTON-(Business Wire)-October 1, 2008 - Drug delivery company, pSivida Corp. (NASDAQ: PSDV)(ASX: PVA)(FF: PV3), together with its licensing and development partner, Alimera Sciences, have today reported the interim six-month safety and efficacy results from the first human pharmacokinetic(i) (PK...
Switzerland Pharmaceuticals and Healthcare Report Q3 2008 Features Essential Independent Forecasts and Competitive Intelligence
DUBLIN, Ireland-(Business Wire)-October 1, 2008 - Research and Markets For more information visit http://www.researchandmarkets.com/research/c31f8e/switzerland_pharma
Aptuit Launches Program to Accelerate Early Stage Drug Development
GREENWICH, Conn.-(Business Wire)-October 1, 2008 - Aptuit Inc. announced today the launch of a new program to accelerate early stage drug development. Aptuit INDiGO(TM) is a fully customizable program that offers an accelerated track from preclinical candidate selection to regulatory submission...
Allos Therapeutics to Present at the JMP Healthcare Focus Conference
WESTMINSTER, Colo.-(Business Wire)-October 1, 2008 - Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that members of the Company's senior management will...
Affymetrix and Medical Prognosis Institute Collaborate to Develop Cancer Treatment Products
SANTA CLARA, Calif.-(Business Wire)-October 1, 2008 - Affymetrix Inc. (Nasdaq:AFFX) and Medical Prognosis Institute A/S (MPI), a leading cancer diagnostic development company based in Denmark, today announced that they have signed a Powered by Affymetrix(TM) (PbA) agreement. With this agreement, MPI...
CIGNA Expands Medicare Offerings for Individuals
BLOOMFIELD, Conn.-(Business Wire)-October 1, 2008 - CIGNA today announced a variety of new programs that will be available to Medicare eligible individuals for 2009. Some of the new offerings include Medicare Part D Prescription Drug plans with no costs for popular generic prescriptions used to...
Alnylam Appoints Industry Leader John Schmidt as Chief Scientific Officer
CAMBRIDGE, Mass.-(Business Wire)-October 1, 2008 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it has appointed John A. Schmidt, Jr., M.D. to the position of Chief Scientific Officer. In this role, Dr. Schmidt will play a critical role in...
Meda: Extended Collaboration with Recordati in Spain
STOCKHOLM, Sweden-(Business Wire)-October 1, 2008 - Regulatory News: Meda (STO:MEDAA) has extended its collaboration with the Italian pharma company Recordati in the cardiovascular area. A long-term agreement has been signed for Lercadip(R) (lercanidipine) in Spain. The product is a calcium...
Geron Supports Governor's Veto of SB1565
MENLO PARK, Calif.-(Business Wire)-October 1, 2008 - Geron Corporation (Nasdaq:GERN) today announced support for California Governor Arnold Schwarzenegger's veto of Senate Bill 1565. The proposed legislation would have implemented a number of changes counter to the original provisions of Proposition...
Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021
BURLINGTON, N.C.-(Business Wire)-October 1, 2008 - Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced today that its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may...
Idera Pharmaceuticals Announces Preliminary Data from Phase 2a Clinical Study of IMO-2055 Monotherapy in Renal Cell Carcinoma
CAMBRIDGE, Mass.-(Business Wire)-October 1, 2008 - Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced preliminary data from the first part of a Phase 2 clinical study conducted by the Company of IMO-2055 monotherapy in patients with metastatic or recurrent clear cell renal carcinoma...
Sirtris' Review of Sirtuin Therapeutics for Diseases of Aging in the Journal Nature Reviews Drug Discovery
CAMBRIDGE, Mass.-(Business Wire)-October 1, 2008 - Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it published a new review article on the growing body of sirtuin research and its potential to...
U.S. Government to Purchase Additional 14.5 Million Doses of BioThrax under New Contract Valued at up to $404 Million
ROCKVILLE, Md.-(Business Wire)-October 1, 2008 - Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a new, multi-year, firm fixed price contract with the U.S. Department of Health and Human Services (HHS) to supply an additional 14.5 million doses of BioThrax(R) (Anthrax...
Biopharmaceutical Contract Manufacturing: Best Practices Pricing Study 2008
SAN JOSE, Calif.-(Business Wire)-October 1, 2008 - HighTech Business Decisions has just published its new study: Biopharmaceutical Contract Manufacturing: Best Practices Pricing Study 2008. This 300-page report documents current industry price and contract practices for biopharmaceutical contract...
Ore Pharmaceuticals Begins Clinical Trial of GL1001
GAITHERSBURG, Md.-(Business Wire)-October 1, 2008 - Ore Pharmaceuticals Inc. (NASDAQ: ORXE) announced today that it has initiated dosing subjects with GL1001, the Company's lead drug candidate, in a multiple ascending dose clinical trial. GL1001, the first clinical-stage inhibitor of the ACE2...
Examine the Russian Pharmaceuticals and Healthcare Industry with this Essential Report, Q3 2008
DUBLIN, Ireland-(Business Wire)-October 1, 2008 - Research and Markets -Stada AG/Nizhpharm -Verofarm *T For more information visit http://www.researchandmarkets.com/research/ee6c23/russia_pharmaceuti
Examine the Markets & Opportunities for Inhaled CNS Therapeutics with This Essential and Comprehensive Report
DUBLIN, Ireland-(Business Wire)-October 1, 2008 - Research and Markets has announced the addition of the "Inhaled CNS Therapeutics - Markets & Opportunities" report to their offering. Delivering drugs to the central nervous system presents unique challenges. But, drug developers and...
BIOTECHNICA 2008 Exhibitor Profiles
HANNOVER, Germany-(Business Wire)-October 1, 2008 - BIOTECHNICA 2008 takes place October 07, 2008 - October 09, 2008 at the Deutsche Messe Exhibition Grounds in Hannover, Germany. Listed below are the BIOTECHNICA 2008 exhibitor profiles. For in-depth information about BIOTECHNICA 2008, visit...
Examine Dry Powder Inhalation Drugs, Devices and Delivery Therapeutics with This Essential and Comprehensive Report
DUBLIN, Ireland-(Business Wire)-October 1, 2008 - Research and Markets has announced the addition of the "Dry Powder Inhalation - Drugs, Devices and Delivery Therapeutics" report to their offering. The convergence of socioeconomic and technology factors - the growing emphasis on drug...
Tranzyme Pharma Announces Positive Phase IIb Results with Its Ghrelin Agonist, TZP-101, for Postoperative Ileus (POI)
RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-October 1, 2008 - Tranzyme Pharma today announced positive Phase IIb results for its first-in-class, highly potent and selective ghrelin agonist, TZP-101, for the management of postoperative ileus (POI). Results demonstrated that TZP-101 was both safe and...
Examine Injectable Drug Delivery Technologies, Targets and Therapeutics with This Essential and Comprehensive Report
DUBLIN, Ireland-(Business Wire)-October 1, 2008 - Research and Markets has announced the addition of the "Injectable Drug Delivery - Technologies, Targets and Therapeutics" report to their offering. Second only to pills and capsules in terms of importance, injectable drug delivery - the...
Examine Delivering Drugs by Inhalation and Emerging Therapeutic Opportunities with This Essential and Comprehensive Report
DUBLIN, Ireland-(Business Wire)-October 1, 2008 - Research and Markets have each found a niche in the quest for optimal treatment and convenient use. While nebulizers have evolved relatively independently of the drug formulations they deliver, the current generation of MDIs and DPIs have been...
Detailed Report Examines the Pharmaceuticals Market in South Africa
DUBLIN, Ireland-(Business Wire)-October 1, 2008 - Research and Markets . Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates. -0- *T Key Topics Covered: - Market Overview - Market Value - Market Segmentation - Market...
Redsense Medical: Bayhealth Medical Center, Delaware, First to Use Redsense Alarm In US
STOCKHOLM, Sweden-(Business Wire)-October 1, 2008 - Redsense Medical has received its first US order from Bayhealth Medical Center, southern Delaware's largest healthcare system. The hospital will start using the Redsense blood loss detection device during hemodialysis. Redsense Medical is currently...
Biotage Divests Biosystems Division to QIAGEN
STOCKHOLM, Sweden-(Business Wire)-October 1, 2008 - Regulatory News: As a result of the Strategic Review of Biotage's (STO:BIOTA) entire operations, launched in October 2007, the Board of Biotage AB ("Biotage") has concluded to divest the Biosystems division ("Biosystems") and the shares in...
Activaero Cooperates with Bayer HealthCare in the Development of Inhaled Treatments
GEMUNDEN, Germany-(Business Wire)-October 1, 2008 - Activaero GmbH, the world leader in controlled breathing technologies for inhaled therapeutic agents, today announced a licensing and option agreement with Bayer HealthCare AG on the development of inhaled treatments. Under the terms of the...
Medivir: New Drug Application (NDA) for Lipsovir(R) Submitted to US FDA
STOCKHOLM, Sweden-(Business Wire)-October 1, 2008 - Regulatory News: Medivir (STO:MVIRB) has today submitted an NDA to the US Food & Drug Administration (FDA) for Lipsovir(R), a topical product for prevention and treatment of cold sores. Lipsovir(R) is a patented combination of hydrocortisone...
Amgen Receives Executive Summary from Independent Cochrane Collaboration Review of ESAs in Oncology
THOUSAND OAKS, Calif.-(Business Wire)-September 30, 2008 - Amgen Inc., (NASDAQ: AMGN) announced it has received a summary of preliminary results from the Cochrane Collaboration's independent meta-analysis of patient-level data from previously conducted, randomized, controlled, clinical studies...
Biogen Idec to Report Third Quarter 2008 Financial Results on October 21, 2008
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - Biogen Idec Inc. (NASDAQ: BIIB) today announced it will report third quarter 2008 financial results on Tuesday, October 21, 2008, before the financial markets open. Following the release of the financials, the Company will host a live webcast...
Incyte to Present at JMP Securities Third Annual Healthcare Focus Conference
WILMINGTON, Del.-(Business Wire)-September 30, 2008 - Incyte Corporation (Nasdaq:INCY) announced today it will present at the JMP Securities Third Annual Healthcare Focus Conference on Monday, October 6, 2008 at 11:00 a.m. (Eastern Time). Paul Friedman, M.D., president and chief executive officer of...
Somaxon Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference and the Second Annual Natixis Hidden Gems Conference
SAN DIEGO-(Business Wire)-September 30, 2008 - Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) today announced that Richard Pascoe, the company's president and chief executive officer, will present a company update at the JMP Securities Healthcare Focus Conference on Monday, October 6, 2008 at 8:30...
SurModics Acquires CodeLink(TM) Activated Slide Business
EDEN PRAIRIE, Minn.-(Business Wire)-September 30, 2008 - SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today the acquisition of the CodeLink(TM) Activated Slide microarray business from GE Healthcare...
Sciele Pharma Announces That Plethora Solutions Has Completed European Phase III Trial of PSD502 for Premature Ejaculation
ATLANTA-(Business Wire)-September 30, 2008 - Sciele Pharma, Inc. ("Sciele") (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that Plethora Solutions Holdings PLC ("Plethora") (AIM:PLE), the specialist developer of products for the treatment and management of urological disorders...
Unigene Enters into Agreement for $20 Million Non-Convertible Debt Financing
BOONTON, N.J.-(Business Wire)-September 30, 2008 - Unigene Laboratories, Inc. (OTCBB: UGNE, http://www.unigene.com) today announced that it has entered into a financing agreement for $20 million three-year non-convertible, senior secured term notes and up to 1,500,000 shares of Common Stock. Unigene...
Research and Markets: Benchmark Glaxosmithkline, Assess the Threat Posed By Generic Competition and Analyze GSK's Future Strategic Direction
DUBLIN, Ireland-(Business Wire)-September 30, 2008 - Research and Markets has announced the addition of the "GlaxoSmithKline plc: PharmaVitae Profile" companyprofile to their offering. This analysis examines the historical and forecast performance for GSK in the ethical pharmaceutical sector. The...
TIGroup Raises $535,000 from Warrant Exercises and Private Placement of Additional Shares of Preferred Stock
BEVERLY HILLS, Calif.-(Business Wire)-September 30, 2008 - Tri-Isthmus Group, Inc. (TIGroup) (Pink Sheets:TISG), a provider of financial solutions to the healthcare industry, said today that exercise of warrants by members of its board of directors, management team and non-affiliated investors has...
Allion Healthcare to Present at Maxim Group Growth Conference
MELVILLE, N.Y.-(Business Wire)-September 30, 2008 - Allion Healthcare (NASDAQ: ALLI) today announced that it will present at the Maxim Group Growth Conference at 8:30 a.m. (Eastern) on Tuesday, October 7, 2008 at the Grand Hyatt Hotel in New York, New York. Mike Moran, Allion's Chairman, President...
Idera Pharmaceuticals to Present at JMP Securities Healthcare Focus Conference
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biopharmaceutical company focused on developing therapeutics targeting Toll-Like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and...
EuroBiO 2008 Is Pleased to Announce the Participation of Internationally Renowned Life Sciences Experts
PARIS-(Business Wire)-September 30, 2008 - EuroBiO 2008, (www.eurobio2008.com), THE Life Sciences Event of the EU Presidency awarded prestigious EU Presidency Label, will take place at the Palais des Congres conference centre in Paris from Tuesday, October 7th to Thursday, October 9th inclusive...
Novalyst Discovery and AliX Agree to Merge / NovAliX Launch
STRASBOURG, France-(Business Wire)-September 30, 2008 - Following long-standing cooperation, Novalyst Discovery, a chemistry services company, and AliX, a structural biology company, have agreed to merge to create a leading CRO. Together they have launched NovAliX, a multidisciplinary company...
SDI Reports: Top 20% of Endocrinologists Write 95% of New-to-Brand Oral Diabetes Prescriptions
YARDLEY, Pa.-(Business Wire)-September 30, 2008 - According to SDI, the leader in innovative analytics for the pharmaceutical and healthcare industries, 20% of endocrinologists who wrote prescriptions for oral diabetes therapies from September 2007 through August 2008 were responsible for 95% of...
The GHC and Aetna celebrate Health Literacy Month
HARTFORD, Conn.-(Business Wire)-September 30, 2008 - Physicians, care providers and other stakeholders in quality health care delivery from across Connecticut are urged to attend an important conference this fall to learn more about the impact poor health literacy and racial and ethnic disparities...
Metabolon and Syngenta Sign Expanded Research Agreement
RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-September 30, 2008 - Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today an expanded, multi-year agreement with Syngenta, a leading global agribusiness. Through this agreement, Syngenta will have access...
Take Care Health Systems Extends Presence in Tennessee with Locations in Knoxville and Memphis
CONSHOHOCKEN, Pa.-(Business Wire)-September 30, 2008 - Take Care Health Systems, one of the largest managers of convenient care clinics and a wholly-owned subsidiary of Walgreens (NYSE, NASDAQ: WAG), has opened locations in Knoxville and Memphis, joining the Nashville market which opened in late...
BIO-Europe 2008: World's Top Pharmaceutical Firms to Gather in Force Seeking Partnerships and Discovering New Ways to Enhance Deal Values
SAN DIEGO & WASHINGTON-(Business Wire)-September 30, 2008 - As partnering transactions continue at record-breaking rates and deals continue as the defining industry trend, the critical question confronting big pharma is not if they should embrace earlier stage deals, but how to best take...
CSL Behring Solicits Proposals for LEAD Grants to Support Patient Advocacy Efforts
KING OF PRUSSIA, Pa.-(Business Wire)-September 30, 2008 - CSL Behring, a global leader in the plasma protein biotherapeutics industry, is soliciting grants to support patient access to care through its Local Empowerment for Advocacy Development (LEAD) program. The LEAD program is committed to...
Pfizer Shows Accelerating Pipeline with Significant Growth in Late-Stage Clinical Development
NEW YORK-(Business Wire)-September 30, 2008 - Pfizer Inc today provided the latest update to its development pipeline, showing significant progress in achieving the company's growth, productivity and performance goals. The pipeline now includes 114 programs, from Phase 1 through Registration. The...
VaxInnate's Second Flu Vaccine Candidate Enters Clinical Development; Results Expected in Early 2009
CRANBURY, N.J.-(Business Wire)-September 30, 2008 - VaxInnate Corporation, a biotechnology company pioneering breakthrough technology to develop novel seasonal and pandemic influenza vaccines, today announced that its second influenza vaccine candidate has entered clinical development. The Phase I...
Survey Finds U.S. Biopharma Industry Is Moving Steadily Toward Secure Distribution
MANHASSET, N.Y. & PALO ALTO, Calif.-(Business Wire)-September 30, 2008 - Pharmaceutical Commerce and Blue Vector Systems today announced survey results reporting the U.S. biopharmaceutical industry's progress in adopting serialization and addressing related supply chain challenges. Conducted...
Cellumen Partners with Alzheimer's Drug Discovery Foundation to Develop New Assays for Early Treatment of Alzheimer's
PITTSBURGH-(Business Wire)-September 30, 2008 - Cellumen, Inc. today announced an agreement with the Alzheimer's Drug Discovery Foundation (ADDF) to apply Cellumen's Cellular Systems Biology (CSB) technology to create a cellular model of Alzheimer's disease. The main objective of the partnership...
AMRI Appoints New Chemistry Director of European Operations
ALBANY, N.Y.-(Business Wire)-September 30, 2008 - AMRI (NASDAQ: AMRI) has named Gergely Makara, Ph.D. as director of chemistry for European operations. Dr. Makara will report to Philip Small, Ph.D. who was promoted from director of chemistry to managing director of AMRI's European operations in June...
Seattle Genetics Adds to Senior Management Team
BOTHELL, Wash.-(Business Wire)-September 30, 2008 - Seattle Genetics, Inc. (Nasdaq: SGEN) today announced the appointments of Elaine Waller, PharmD to Senior Vice President, Regulatory Affairs and Christopher Pawlowicz to Senior Vice President, Human Resources, as well as the promotion of Jonathan...
Koronis Pharmaceuticals Announces Appointment of Prominent HIV Researcher Courtney Fletcher, Pharm. D., to Scientific Advisory Board and Jeff Parkins as VP, Clinical Development
SEATTLE-(Business Wire)-September 30, 2008 - Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced that Courtney Fletcher, Pharm. D., will join the Company's Scientific Advisory Board and Jeff Parkins has been promoted to Vice...
Aeolus Pharmaceuticals Announces Initiation of Multiple Dose Study of AEOL 10150 in a Patient with ALS
LAGUNA NIGUEL, Calif.-(Business Wire)-September 30, 2008 - Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today that it has initiated a follow-on Phase I open label compassionate use multiple dose study of AEOL 10150 in a patient diagnosed with progressive and debilitating amyotrophic...
GE Healthcare Acquires MicroCal Broadening Capabilities in Biomedical and Pharmaceutical Research
CHALFONT ST. GILES, England-(Business Wire)-September 30, 2008 - GE Healthcare, a unit of General Electric Company (NYSE:GE), today announced it has acquired MicroCal LLC, a provider of innovative instruments for the study of molecular interactions in pharmaceutical, biomedical and life science...
CalciTech Reports Interim Results
GENEVA, Switzerland-(Business Wire)-September 30, 2008 - CalciTech Ltd.(Plus Markets:CLK) (OTCBB:CLKTF) today announces the results for the first six months of the financial year 2008. Net loss for the period ending 30th June 2008 was $484,000, a decrease of $61,000 compared to the first six...
Link Medicine Completes $40 million Series C Financing to Accelerate Development of First Disease-Modifying Treatments for Neurodegenerative Disorders
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - Link Medicine Corporation, a privately held biotechnology company advancing novel approaches for the treatment of neurodegenerative diseases, announced today that it has obtained $40 million of Series C equity financing to help move its lead...
Cempra Pharmaceuticals and Biovista Enter Agreement for Macrolide Clinical Trial Design Support Studies
CHAPEL HILL, N.C. & CHARLOTTESVILLE, Va.-(Business Wire)-September 30, 2008 - Cempra Pharmaceuticals, Inc., and Biovista, Inc., announced today that they have entered into a research agreement to systematically identify and profile adverse event associations for members of the macrolide drug...
AVEO Pharmaceuticals to Present at the Third Annual JMP Securities Healthcare Focus Conference
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - AVEO Pharmaceuticals, Inc. today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the Third Annual JMP Securities Healthcare Focus Conference on Tuesday, October 7, 2008 at 3:00 p.m. (ET) at the Le...
Oxygen Biotherapeutics, Inc. to Present at Rodman & Renshaw Investment Conference in New York City on Nov. 12
COSTA MESA, Calif.-(Business Wire)-September 30, 2008 - Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) today announced that company chairman and CEO Chris J. Stern, DBA will present at the Rodman & Renshaw Annual Global Investment Conference in New York on November 12, 2008 at 12:25 p.m. eastern...
Enzon's New Oncaspar-IV(TM) Receives Orphan Drug Status in The EU
BRIDGEWATER, N.J.-(Business Wire)-September 30, 2008 - Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced today that Oncaspar-IV(TM), the next generation pegylated L-asparaginase, received approval from the Commission of the European Communities for designation as an orphan medicinal product...
Synta Pharmaceuticals to Present at the Third Annual JMP Securities Healthcare Focus Conference
LEXINGTON, Mass.-(Business Wire)-September 30, 2008 - Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the...
Acceleron to Present at Third Annual JMP Securities Healthcare Focus Conference
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that John Knopf, Ph.D., Chief Executive Officer of Acceleron, will provide a...
Advinus Therapeutics (P) Ltd. and Ortho-McNeil-Janssen Pharmaceuticals, Inc. Establish Drug Discovery and Development Collaboration
BANGALORE, India-(Business Wire)-September 30, 2008 - Advinus Therapeutics (P) Ltd., a TATA Enterprise has announced a drug discovery and development collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI). Under the agreement, Advinus and OMJPI have agreed to develop drug candidates...
Ramsell Public Health Rx Launches Nationwide Pharmacy Discount Card for Public Health Programs
OAKLAND, Calif.-(Business Wire)-September 30, 2008 - Ramsell Public Health Rx, a pharmacy benefit manager and information management company, today announces the launch of the Pharmacy Discount Card website www.publichealthrx.com/discountcard. The free drug discount card site will allow the more...
Curis to Present at Maxim Group Growth Conference 2008
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing next generation proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the Maxim Group Growth Conference 2008, which...
Pfizer's George Rathbun Named Chief Technology Officer, CRIX International
RESTON, Va.-(Business Wire)-September 30, 2008 - Clinical Research Information eXchange (CRIX) International announced today that George Rathbun, a Director in Pfizer's Development and Medical Informatics organization, has been named Chief Technology Officer (CTO). Pfizer, Inc. has seconded Mr...
Get the Latest Independent Forecasts and Competitive Intelligence with Hungary Pharmaceuticals and Healthcare Report Q3 2008
DUBLIN, Ireland-(Business Wire)-September 30, 2008 - Research and Markets Eli Lilly Krka BMI Forecast Modelling For more information visit http://www.researchandmarkets.com/research/4aaea3/hungary_pharmaceut
Examine the OTC Pharmaceuticals in Australia
DUBLIN, Ireland-(Business Wire)-September 30, 2008 - Research and Markets and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates. Asia-Pacific comprises Australia, China, Japan, India...
Obtain Competitive Intelligence with Latvia Pharmaceuticals and Healthcare Report Q3 2008
DUBLIN, Ireland-(Business Wire)-September 30, 2008 - Research and Markets Olainfarm For more information visit http://www.researchandmarkets.com/research/978284/latvia_pharmaceuti
ZIOPHARM Oncology to Present at Maxim Group Growth Investor Conference
NEW YORK-(Business Wire)-September 30, 2008 - ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the Maxim Group Growth Investor Conference on Tuesday, October 7, 2008 at 3:30 pm ET in the Morosco room at the Grand Hyatt Hotel...
BioChemics, Inc. Announces Collaboration Agreement with Leading Light Based Technology Company
DANVERS, Mass.-(Business Wire)-September 30, 2008 - BioChemics, Inc. (BCI), a company "enhancing drug delivery through biophysical modulation," is pleased to announce the signing of a research collaboration agreement with Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of...
Examine the Pharmaceuticals and Healthcare Industry in the United Kingdom With This Essential Q3 2008 Report
DUBLIN, Ireland-(Business Wire)-September 30, 2008 - Research and Markets CEO's growing focus on emerging markets and positive performances from Alliance Boots and Shire's decision to establish a new parent company in Ireland, as a result of the country's tax benefits. -0- *T Key Topics Covered...
APT Pharmaceuticals Secures $32 Million in Series B Financing
BURLINGAME, Calif.-(Business Wire)-September 30, 2008 - APT Pharmaceuticals, a specialty drug development company focused on inhaled treatments for serious lung diseases, announced today the completion of a $32.3 million Series B financing. The financing was led by Three Arch Partners and joined...
Phase 2 Study of IMC-1121B for Advanced Ovarian Cancer Commences Patient Enrollment
NEW YORK-(Business Wire)-September 30, 2008 - ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that the first patient has been treated in its disease-directed Phase 2 clinical trial of IMC-1121B...
Spectrum Pharmaceuticals to Present at the JMP Securities Focus on Healthcare Conference
IRVINE, Calif.-(Business Wire)-September 30, 2008 - Spectrum Pharmaceuticals, Inc., (NasdaqGM:SPPI) announced today that an overview of the Company's business strategy will be presented at the JMP Securities Focus on Healthcare conference on Tuesday, October 7, 2008, at 10:00 a.m. Eastern/7:00...
Search Our News Using Google Search
Can't find what you want? Try using Google:
